# Clinical Study to Evaluate the Safety and Performance of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction

> **NCT04224155** · NA · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 165 (actual)

## Conditions studied

- Cataract

## Interventions

- **DEVICE:** enVista MX60EFH trifocal intraocular lenses (IOLs)
- **DEVICE:** enVista MX60E monofocal intraocular lenses (IOLs)

## Key facts

- **NCT ID:** NCT04224155
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-10
- **Primary completion:** 2022-06-14
- **Final completion:** 2022-06-14
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2024-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04224155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04224155, "Clinical Study to Evaluate the Safety and Performance of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04224155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*